[HTML][HTML] Ribavirin in the treatment of SARS: A new trick for an old drug?
G Koren, S King, S Knowles, E Phillips - Cmaj, 2003 - Can Med Assoc
* The treatment dose of ribavirin has been reduced significantly from earlier
recommendations because of a lack of information to support the in vitro efficacy of ribavirin …
recommendations because of a lack of information to support the in vitro efficacy of ribavirin …
Adverse effects of ribavirin and outcome in severe acute respiratory syndrome: experience in two medical centers
Study objectives To assess the effect of ribavirin-induced anemia on the outcome of severe
acute respiratory syndrome (SARS). Design A retrospective observational study. Setting Two …
acute respiratory syndrome (SARS). Design A retrospective observational study. Setting Two …
Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings
Background: The clinical response of patients with severe acute respiratory syndrome
(SARS) to a combination of lopinavir/ritonavir and ribavirin was examined after establishing …
(SARS) to a combination of lopinavir/ritonavir and ribavirin was examined after establishing …
[PDF][PDF] Pharmacologic treatment of SARS: current knowledge and recommendations
DYH Tai - Annals-Academy of Medicine Singapore, 2007 - annals.edu.sg
The severe acute respiratory syndrome (SARS) pandemic caught the world by surprise in
2003 and spread rapidly within a relatively short period of time. Hence, randomised …
2003 and spread rapidly within a relatively short period of time. Hence, randomised …
[HTML][HTML] SARS: systematic review of treatment effects
LJ Stockman, R Bellamy, P Garner - PLoS medicine, 2006 - journals.plos.org
Background The SARS outbreak of 2002–2003 presented clinicians with a new, life-
threatening disease for which they had no experience in treating and no research on the …
threatening disease for which they had no experience in treating and no research on the …
Investigational use of ribavirin in the treatment of severe acute respiratory syndrome, Singapore, 2003
Objective Ribavirin is a broad spectrum nucleoside analogue efficacious in the treatment of
several viral infections. In the recent severe acute respiratory syndrome (SARS) outbreak …
several viral infections. In the recent severe acute respiratory syndrome (SARS) outbreak …
Novel coronavirus and severe acute respiratory syndrome
AR Falsey, EE Walsh - The Lancet, 2003 - thelancet.com
Peiris and colleagues suggest that early therapy with intravenous ribavirin and high-dose
glucocorticosteroids may be beneficial. However, the lack of untreated control patients …
glucocorticosteroids may be beneficial. However, the lack of untreated control patients …
Adverse events associated with high‐dose ribavirin: evidence from the Toronto outbreak of severe acute respiratory syndrome
Study Objectives. To distinguish adverse events related to ribavirin therapy from those
attributable to severe acute respiratory syndrome (SARS), and to determine the rate of …
attributable to severe acute respiratory syndrome (SARS), and to determine the rate of …
Common adverse events associated with the use of ribavirin for severe acute respiratory syndrome in Canada
SR Knowles, EJ Phillips, L Dresser… - Clinical infectious …, 2003 - academic.oup.com
Although information on efficacy and adverse drug reactions is lacking, ribavirin has been
used empirically for the treatment of severe acute respiratory syndrome (SARS). We report …
used empirically for the treatment of severe acute respiratory syndrome (SARS). We report …
Current concepts in SARS treatment
T Fujii, T Nakamura, A Iwamoto - Journal of infection and chemotherapy, 2004 - Springer
The outbreak of severe acute respiratory syndrome (SARS) has drawn enormous attention
and caused fear worldwide since early 2003. The disease appears to be under control now; …
and caused fear worldwide since early 2003. The disease appears to be under control now; …